On this page
What each program costs in South Dakota
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does South Dakota Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
South Dakota Medicaid's pharmacy manual lists agents used for weight loss as not covered, and its Wegovy form says not covered for obesity or weight management. Read from state documents Nov 6, 2026.
What South Dakota Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. South Dakota Department of Social Services, Division of Medicaid.
WegovyNo
Prior authorization form lists heart risk in members without diabetes and MASH in members without diabetes.
“Not covered for obesity or weight management or Type 2 diabetes mellitus”
South Dakota Department of Social Services, Medicaid (OptumRx form) · No effective date on the document · read Nov 6, 2026
“Agents used for anorexia, weight loss, weight gain, hair growth or cosmetic purposes”
South Dakota Department of Social Services, Medicaid · No effective date on the document · read Nov 6, 2026
ZepboundNo
Agents used for weight loss are not covered. No Zepbound form could be read, so other covered uses were not confirmed.
“Agents used for anorexia, weight loss, weight gain, hair growth or cosmetic purposes”
South Dakota Department of Social Services, Medicaid · No effective date on the document · read Nov 6, 2026
OzempicNo
Agents used for weight loss are not covered. The GLP-1 prior authorization form lists type 2 diabetes as a diagnosis option.
“Agents used for anorexia, weight loss, weight gain, hair growth or cosmetic purposes”
South Dakota Department of Social Services, Medicaid · No effective date on the document · read Nov 6, 2026
“GLP-1 Agonists Prior Authorization Request Form”
South Dakota Department of Social Services, Medicaid (OptumRx form) · No effective date on the document · read Nov 6, 2026
MounjaroNo
Agents used for weight loss are not covered. The GLP-1 prior authorization form lists type 2 diabetes as a diagnosis option.
“Agents used for anorexia, weight loss, weight gain, hair growth or cosmetic purposes”
South Dakota Department of Social Services, Medicaid · No effective date on the document · read Nov 6, 2026
“GLP-1 Agonists Prior Authorization Request Form”
South Dakota Department of Social Services, Medicaid (OptumRx form) · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from South Dakota Department of Social Services, Division of Medicaid documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
0 prescriptions
Ozempic and Mounjaro, 2025
14,273 prescriptions
Neighbours covering weight loss
1 of 6
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your South Dakota Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed South Dakota Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether South Dakota Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does South Dakota Medicaid pay for?
15,521 GLP-1 prescriptions in 2025, 49th of the 50 states and DC, with $15.4 million reimbursed before rebates. Counting the share other payers covered, $15.7 million.
Prescriptions, 2025
15,521
49th of 51
Medicaid paid
$15.4M
49th of 51, before rebates
Per prescription
$990
$1,051 nationally
Weight-loss brands
0.0%
50th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. South Dakota is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.0% of South Dakota Medicaid's GLP-1 prescriptions in 2025 (0). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Mounjaro was South Dakota Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Mounjaro | 7,486 | 48% | $7.7 million | $1,023 |
| Ozempic | 6,787 | 44% | $6.5 million | $964 |
| Trulicity | 743 | 4.8% | $719,820 | $969 |
| Rybelsus | 423 | 2.7% | $398,136 | $941 |
| Liraglutide (generic) | 82 | 0.5% | $46,638 | $569 |
| Wegovyapproved for weight management | 0 | 0.0% | $0 | n/a |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in South Dakota?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
South Dakota and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 6 states next to South Dakota covers GLP-1s for weight loss through Medicaid: Minnesota. None has a lower cash floor than South Dakota's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| South Dakota | Not covered | 19 | $39/mo |
| Iowa | Not covered | 19 | $39/moWellmedr |
| Minnesota | Covered | 19 | $39/moWellmedr |
| Montana | Not covered | 19 | $39/moWellmedr |
| Nebraska | Not covered | 19 | $39/moWellmedr |
| North Dakota | Not covered | 17 | $39/moWellmedr |
| Wyoming | Not covered | 19 | $39/moWellmedr |






















